Pregnancy Related Clinical Trial
Official title:
Safe Maternity Care Through Immediate Provision of Highly-effective Postpartum Contraception
This is a multicenter observational study of implementation of postpartum contraceptive counseling and provision into the maternity care setting in Colombia, South America. The primary aim is to determine proportion of uptake of highly-effective contraceptive use after these methods become available immediately postpartum. Secondary aims include rapid repeat pregnancy rates, use of other types of contraception, breastfeeding continuation, and visualization of IUD strings after immediate postpartum placement.
This pre- post-intervention study will take place in Colombia, South America in 2 cities:
Medellin (2 sites and Cartagena 1 site). The main objective is to determine the proportion of
contraceptive usage by women who have just had a baby, before and after the introduction of
specialized contraceptive counseling into maternity care and availability of the most
effective contraceptive methods:
Group 1 (Standard of care) participants will be asked about intention for contraception usage
upon hospital discharge after maternity care.
Group 2 (Intervention) participants will receive standardized contraceptive counseling and
immediate access to the method of choice, including long acting reversible contraception
(LARC) and other locally available methods. LARC methods available in Colombia include the
copper-T intrauterine device (IUD) and Jadelle® implant, both of which are safe for usage in
postpartum women.
Both groups will undergo follow- up via phone at 6-8 weeks, and 6 and 12 months postpartum to
determine contraceptive continuation, repeat pregnancy, and to track any complications with
the usage of LARC, including infection and contraceptive failure. For subjects with an IUD,
an additional visit would take place at 8-10 days to determine need for IUD string trimming
and visualization of strings.
The intervention will include introduction of specialized standardized contraceptive
counseling to occur during inpatient maternity care and immediate postpartum availability of
LARC methods. Currently, contraceptive counseling is left to the postpartum primary care
setting and obstetric providers are not trained for immediate IUD placement. LARC devices are
not typically available in the inpatient setting. Providers and staff of all levels will be
trained in standardized contraceptive counseling methods. Obstetric providers will be trained
in immediate postplacental IUD insertion. Staff nurses and providers will have access to
company-sponsored implant insertion training programs.
The proportion of participants using LARC methods after implementation of the intervention
will be compared to the proportion choosing LARC prior to the intervention. Additionally, the
outcomes of women choosing non-LARC methods will be compared to those choosing LARC methods.
The study has received funding by the Colombian grant agency, Colciencias. Regulatory
oversight has previously been granted by the University of Antioquia's (Medellin, Colombia)
Institutional Review Board. Research operations are managed by the local Colombian
organization, NACER, with support of research design and methods, statistical analysis, and
medical expertise and trainings provided by clinicians from OHSU. Day to day research
operations will be managed by research coordinators at each of the three maternity care
hospital sites with support and monitoring by NACER and by OHSU clinicians.
The role of OHSU clinicians will be to provide research infrastructure and clinical support
via remote communications, to provide initial training of trainers, to provide monitoring of
recruitment and counseling methods, to help in the creation and monitor quality of data
collection forms, and to perform statistical analyses. OHSU will not participate in
recruitment of participants or in clinical procedures. We do not plan to be present at any
research sites in person, though may perform monitoring visits if funds are available.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A |